Skip to main content
Livermore
Livermore
ZHEN

Central Trust Co

SEC CIK
0000044365
Latest filing
Jul 31, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Central Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
1,444
Value
$900.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Central Trust Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,444$900.4K<0.1%+369+34.3%AddedHolders
Q1 20261,075$830.6K<0.1%+324+43.1%AddedHolders
Q4 2025751$579.3K<0.1%+232+44.7%AddedHolders
Q3 2025519$291.8K<0.1%−673−56.5%ReducedHolders
Q2 20251,192$625.8K<0.1%−1,069−47.3%ReducedHolders
Q1 20252,261$1.43M<0.1%−205−8.3%ReducedHolders
Q4 20242,466$1.76M<0.1%+1,021+70.7%AddedHolders
Q3 20241,445$1.52M<0.1%−333−18.7%ReducedHolders
Q2 20241,778$1.87M<0.1%−133−7.0%ReducedHolders
Q1 20241,911$1.84M<0.1%−61−3.1%ReducedHolders
Q4 20231,972$1.73M<0.1%−115−5.5%ReducedHolders
Q3 20232,087$1.72M<0.1%−613−22.7%ReducedHolders
Q2 20232,700$1.94M0.1%−981−26.7%ReducedHolders
Q1 20233,681$3.02M0.1%−818−18.2%ReducedHolders
Q4 20224,499$3.25M0.1%−326−6.8%ReducedHolders
Q3 20224,825$3.32M0.1%−72−1.5%ReducedHolders
Q2 20224,897$2.89M0.1%−1,907−28.0%ReducedHolders
Q1 20226,804$4.75M0.1%+196+3.0%AddedHolders
Q4 20216,608$4.17M0.1%−65−1.0%ReducedHolders
Q3 20216,673$4.04M0.1%+223+3.5%AddedHolders
Q2 20216,450$3.60M0.1%−702−9.8%ReducedHolders
Q1 20217,152$3.38M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.